Old Drugs, New Tricks: FDA’s Drug Repurposing Initiative May 26, 2026 By Charles D. Snow & Kalie E. Richardson —

https://www.thefdalawblog.com/2026/05/old-drugs-new-tricks-fdas-drug-repurposing-initiative/?utm_source=rss&utm_medium=rss&utm_campaign=old-drugs-new-tricks-fdas-drug-repurposing-initiative Don’t look now, but drug repurposing is having a moment. On May 11, 2026, FDA announced a new public docket soliciting stakeholder input on its drug repurposing initiative—specifically, which chronic disease areas should be prioritized and which approved drugs have the most potential to treat conditions outside their existing labels. The accompanying Federal Register notice (Docket No. FDA-2026-N-4492) has a comment deadline of June 11, 2026, which means the clock is already ticking. In parallel, FDA launched a dedicated “Drug Repurposing” webpage.